Calculation of your study is finished. Please find your results below.

A study for a 73 year old man who takes Lipitor, Rizatriptan Benzoate, Buspar (an AI-powered real world drug study)

Summary:

289 males aged 73 (±5) who take the same drugs and have adverse effects are studied. This is a phase IV clinical study for a 73 year old male patient who has High Cholesterol, Migraine, Anxiety. The study is created by eHealthMe based on reports from sources including the FDA.


On Aug, 10, 2026

289 males aged 73 (±5) who take Lipitor, Rizatriptan Benzoate, Buspar and have adverse effects are studied.


Number of reports submitted per year:

Lipitor, Rizatriptan Benzoate, Buspar for a 73-year old man.

Information of the patient in this study:

  • Age: 73
  • Gender: male

What are the drugs?

What are the conditions?


Common drug interactions *:

  1. Fatigue (feeling of tiredness): 25 people, 8.65%
  2. Death : 23 people, 7.96%
  3. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 19 people, 6.57%
  4. Chronic Kidney Disease : 16 people, 5.54%
  5. Acute Kidney Failure : 16 people, 5.54%
  6. Weakness : 13 people, 4.50%
  7. Rashes (redness): 13 people, 4.50%
  8. Nonspecific Reaction (unspecified reaction): 13 people, 4.50%
  9. Dizziness : 12 people, 4.15%
  10. Diarrhea : 12 people, 4.15%
  11. Blood Glucose Increased : 12 people, 4.15%
  12. Nausea (feeling of having an urge to vomit): 11 people, 3.81%
  13. Fall : 11 people, 3.81%
  14. Urinary Tract Infection : 11 people, 3.81%
  15. Hypotension (abnormally low blood pressure): 11 people, 3.81%
  16. Drowsiness : 10 people, 3.46%
  17. Confusional State : 10 people, 3.46%
  18. Constipation : 9 people, 3.11%
  19. Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 9 people, 3.11%
  20. Dyspnea (difficult or laboured breathing): 9 people, 3.11%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

  1. Parkinson's Disease : 28 people, 9.69%
  2. Pain : 27 people, 9.34%
  3. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 23 people, 7.96%
  4. Multiple Myeloma (cancer of the plasma cells): 22 people, 7.61%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 21 people, 7.27%
  6. Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 18 people, 6.23%
  7. Cardiac Disorder : 16 people, 5.54%
  8. Constipation : 14 people, 4.84%
  9. Hallucinations (sensations that appear real but are created by your mind): 12 people, 4.15%
  10. Diabetes : 11 people, 3.81%
  11. Sleep Disorder : 10 people, 3.46%
  12. Hyperlipidaemia (presence of excess lipids in the blood): 10 people, 3.46%
  13. Delusion (a false belief or opinion): 9 people, 3.11%
  14. Coronary Heart Disease (narrowing or blockage of the coronary arteries): 9 people, 3.11%
  15. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 8 people, 2.77%
  16. Insomnia (sleeplessness): 8 people, 2.77%
  17. Type 2 Diabetes : 8 people, 2.77%
  18. Neuropathy Peripheral (surface nerve damage): 7 people, 2.42%
  19. Gout (uric acid crystals building up in the body): 7 people, 2.42%
  20. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 2.42%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

  1. Aspirin (55 people, 19.03%)
  2. Vitamin D3 (40 people, 13.84%)
  3. Tamsulosin (39 people, 13.49%)
  4. Nuplazid (34 people, 11.76%)
  5. Amlodipine (34 people, 11.76%)
  6. Metformin (30 people, 10.38%)
  7. Xarelto (27 people, 9.34%)
  8. Melatonin (26 people, 9.00%)
  9. Lantus (25 people, 8.65%)
  10. Sertraline (25 people, 8.65%)
  11. Flomax (25 people, 8.65%)
  12. Eliquis (24 people, 8.30%)
  13. Lisinopril (24 people, 8.30%)
  14. Prilosec (22 people, 7.61%)
  15. Pantoprazole (22 people, 7.61%)
  16. Tylenol (20 people, 6.92%)
  17. Clopidogrel (19 people, 6.57%)
  18. Omeprazole (19 people, 6.57%)
  19. Plavix (19 people, 6.57%)
  20. Lyrica (18 people, 6.23%)

Drug effectiveness *:

Lipitor:
  • not at all: 0 %
  • somewhat: 33.33 %
  • moderate: 0 %
  • high: 66.67 %
  • very high: 0 %
Rizatriptan Benzoate:
  • not at all: 0 %
  • somewhat: 0 %
  • moderate: 0 %
  • high: 100 %
  • very high: 0 %
Buspar:
  • not at all: 0 %
  • somewhat: 0 %
  • moderate: 0 %
  • high: 100 %
  • very high: 0 %

* Some reports may have incomplete information.


How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Drug side effects in long term, by gender and age:

Treatments, associated medications and conditions:

Drug interactions:

How the phase IV clinical study uses the data?

The study is based on gender, age, active ingredients of any drugs used. Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: